DrugPatentWatch Database Preview
Exela Pharma Scs Llc Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for EXELA PHARMA SCS LLC, and when can generic versions of EXELA PHARMA SCS LLC drugs launch?
EXELA PHARMA SCS LLC has eleven approved drugs.
There are two US patents protecting EXELA PHARMA SCS LLC drugs.
Summary for Exela Pharma Scs Llc
| US Patents: | 2 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 11 |
Drugs and US Patents for Exela Pharma Scs Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma Scs Llc | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 018925-001 | Mar 30, 1984 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Exela Pharma Scs Llc | GANZYK-RTU | ganciclovir | SOLUTION;INTRAVENOUS | 209347-001 | Feb 17, 2017 | RX | Yes | Yes | 9,486,530 | Start Trial | Y | Start Trial | |||
| Exela Pharma Scs Llc | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-001 | Jul 11, 2018 | RX | No | No | Start Trial | Start Trial | |||||
| Exela Pharma Scs Llc | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 10,478,453 | Start Trial | Y | Start Trial | |||
| Exela Pharma Scs Llc | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 206203-001 | Dec 29, 2015 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Exela Pharma Scs Llc | VERAPAMIL HYDROCHLORIDE | verapamil hydrochloride | SOLUTION;INTRAVENOUS | 018925-002 | Apr 5, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
